膀胱全切原位尿流改道術后并發(fā)癥分析及生活質量評估
發(fā)布時間：2018-08-25 12:28
【摘要】：[目的]對接受膀胱全切原位尿流改道術的病人,進行術后近期和遠期并發(fā)癥統(tǒng)計分析,并使用FACT-BL量表評估患者生活質量,為進一步研究原位尿流改道術提供依據(jù)。[方法]本研究回顧性分析昆明醫(yī)科大學第二附屬醫(yī)院泌尿外科2014年1月至2016年11月以來68例因膀胱癌行膀胱全切原位尿流改道術患者的術后并發(fā)癥發(fā)生情況,并使用FACT-BL量表評估患者生活質量。[結果]全部68例患者接受膀胱全切原位尿流改道術,并全部獲得長期隨訪�；颊吣挲g39-79歲,平均年齡60.34±9.43歲�；颊呤中g順利完成,術后恢復良好,均康復出院。在完成隨訪的68例患者中,出現(xiàn)早期并發(fā)癥10例(14.71%),出現(xiàn)晚期并發(fā)癥 11 例(17. 64%);術前術后血清 Cr 對比(t=1.305, P=0.196),BUN 對比(t=0.358,P=0.764),二者差別均無統(tǒng)計學意義;術前術后K+對比(t=1.347,P=0.169),Na+對比(t=-1.748, P=0.144), Ca+對比(t=1.097, P=0.319 ),差別均無統(tǒng)計學意義;C1-對比(t=-4.701,P=0.000),差別具有統(tǒng)計學意義;通過加強排尿功能訓練,隨訪1年,白天可控排尿56例(93. 33%),20例出現(xiàn)夜間尿失禁(33. 33%);術后6個月,新膀胱容量(365.02±45.11)ml,最大尿流率(14.36±1.41)ml/s,殘余尿量(26.01±8. 10) ml;術后隨訪 12 個月,FACT-BL 總分 124. 8± 13. 4。[結論]經過1年的隨訪,原位新膀胱患者術后早期及晚期并發(fā)癥均在可接受的范圍內,白天與夜間的控尿率均可達到日常生活的要求,水電解質平衡紊亂情況較少,上尿路功能恢復良好,新膀胱較接近生理狀態(tài)的儲尿、排尿功能。原位新膀胱術既保存了身體外觀上的完整性,又接近于正常膀胱生理特性,明顯地提高患者的術后生活質量,患者易于接受,是一種比較理想的手術方式。
[Abstract]:[objective] to evaluate the quality of life (QOL) of patients undergoing total cystectomy and in situ urethral diversion with FACT-BL scale, and to provide a basis for further study of in situ urethral diversion. [methods] from January 2014 to November 2016, 68 patients with bladder cancer undergoing total cystectomy and in-situ urinary diversion were analyzed retrospectively. The quality of life (QOL) was evaluated with FACT-BL scale. [results] all 68 patients underwent total cystectomy and in situ urethral diversion, and all received long-term follow-up. The average age of the patients was 60.34 鹵9.43 years. All patients recovered and were discharged from hospital. Of the 68 patients, 10 (14. 71%) had early complications and 11 (17. 7%) had late complications. There was no significant difference in serum Cr before and after operation (t = 1.305, P = 0.196) and bun (t = 0.358, P ~ (0.764), but there was no significant difference in preoperative and postoperative K (t ~ (1.347) P ~ (0.169) and Na (t ~ (1) -1.748, P ~ (0.144), Ca) (t ~ (1.097, P ~ (0.319), there was no significant difference (t ~ (-4.701) P ~ (0.000). 56 cases (93. 3%) of controlled urination during the day were followed up for 1 year by strengthening the training of urination function. The incidence of nocturnal urinary incontinence was 33% (20 / 20). At 6 months after operation, the maximal urinary flow rate of ml, was (365.02 鹵45.11) ml, (14.36 鹵1.41) ml/s, residual urine volume (26.01 鹵8). 10) the total FACT-BL score of 12 months after ml; operation was 124. 8 鹵13. 4. [conclusion] after one year's follow-up, the early and late complications of patients with neobladder in situ were within the acceptable range, the urinary control rate during the day and at night could meet the requirements of daily life, and the disturbance of water and electrolyte balance was less. The upper urinary tract function recovered well, the new bladder was close to the physiological state of urine storage and urination function. New bladder surgery in situ not only preserves the integrity of the body appearance, but also approaches the normal bladder physiological characteristics. It obviously improves the quality of life of the patients after operation and is easily accepted by the patients. It is an ideal operation method.
【學位授予單位】：昆明醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R737.14
本文編號：2202886
[Abstract]:[objective] to evaluate the quality of life (QOL) of patients undergoing total cystectomy and in situ urethral diversion with FACT-BL scale, and to provide a basis for further study of in situ urethral diversion. [methods] from January 2014 to November 2016, 68 patients with bladder cancer undergoing total cystectomy and in-situ urinary diversion were analyzed retrospectively. The quality of life (QOL) was evaluated with FACT-BL scale. [results] all 68 patients underwent total cystectomy and in situ urethral diversion, and all received long-term follow-up. The average age of the patients was 60.34 鹵9.43 years. All patients recovered and were discharged from hospital. Of the 68 patients, 10 (14. 71%) had early complications and 11 (17. 7%) had late complications. There was no significant difference in serum Cr before and after operation (t = 1.305, P = 0.196) and bun (t = 0.358, P ~ (0.764), but there was no significant difference in preoperative and postoperative K (t ~ (1.347) P ~ (0.169) and Na (t ~ (1) -1.748, P ~ (0.144), Ca) (t ~ (1.097, P ~ (0.319), there was no significant difference (t ~ (-4.701) P ~ (0.000). 56 cases (93. 3%) of controlled urination during the day were followed up for 1 year by strengthening the training of urination function. The incidence of nocturnal urinary incontinence was 33% (20 / 20). At 6 months after operation, the maximal urinary flow rate of ml, was (365.02 鹵45.11) ml, (14.36 鹵1.41) ml/s, residual urine volume (26.01 鹵8). 10) the total FACT-BL score of 12 months after ml; operation was 124. 8 鹵13. 4. [conclusion] after one year's follow-up, the early and late complications of patients with neobladder in situ were within the acceptable range, the urinary control rate during the day and at night could meet the requirements of daily life, and the disturbance of water and electrolyte balance was less. The upper urinary tract function recovered well, the new bladder was close to the physiological state of urine storage and urination function. New bladder surgery in situ not only preserves the integrity of the body appearance, but also approaches the normal bladder physiological characteristics. It obviously improves the quality of life of the patients after operation and is easily accepted by the patients. It is an ideal operation method.
【學位授予單位】：昆明醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R737.14
【參考文獻】
相關期刊論文 前10條
1 孟一森;蘇楊;范宇;虞巍;王宇;鄭衛(wèi);諶誠;周利群;張騫;李學松;韓文科;何志嵩;金杰;;根治性膀胱全切術后腸梗阻的危險因素分析(附740例報道)[J];北京大學學報(醫(yī)學版);2015年04期
2 詹輝;王劍松;徐鴻毅;左毅剛;丁明霞;柯昌興;顏汝平;王海峰;;膀胱癌原位新膀胱術后尿瘺影響因素分析[J];現(xiàn)代泌尿外科雜志;2014年03期
3 韓蘇軍;張思維;陳萬青;李長嶺;;中國膀胱癌發(fā)病現(xiàn)狀及流行趨勢分析[J];癌癥進展;2013年01期
4 鄭少波;劉春曉;徐亞文;方平;郭凱;杜偉;溫勇;;全膀胱切除、去帶乙狀結腸新膀胱術后近期并發(fā)癥分析[J];實用醫(yī)學雜志;2011年09期
5 周芳堅;余紹龍;熊永紅;李永紅;劉卓煒;韓輝;秦自科;;全膀胱切除和原位新膀胱術并發(fā)癥的預防和處理[J];臨床泌尿外科雜志;2008年07期
6 王劍松;徐鴻毅;石永福;詹輝;李炯明;李澤惠;左毅剛;楊德林;王超;柯昌興;丁明霞;顏汝平;;原位回腸和乙狀結腸尿流改道術臨床療效比較[J];中華泌尿外科雜志;2006年12期
7 萬崇華;孟瓊;湯學良;張燦珍;羅家洪;張曉磐;;癌癥患者生命質量測定量表FACT-G中文版評介[J];實用腫瘤雜志;2006年01期
8 郭艷麗,閆慧明,宋善俊;組織因子在結腸癌表達的臨床意義(英文)[J];中國現(xiàn)代醫(yī)學雜志;2005年15期
9 胡雁,Ken Sellick;消化道惡性腫瘤病人確診初期生命質量縱向研究[J];護理學雜志;2003年10期
10 葉敏;Studer回腸代膀胱術的技術改進和臨床應用[J];中華泌尿外科雜志;2003年10期
，本文編號：2202886
本文鏈接：http://www.wukwdryxk.cn/yixuelunwen/zlx/2202886.html
最近更新
教材專著
